-
1061
-
1062
-
1063
Research on application of tumor treating fields in glioblastoma: A bibliometric and visual analysis
Published 2022-11-01“…STUPP R (236) was the most cited author followed by KIRSON ED (164) and GILADI M (104). JOURNAL OF NEURO-ONCOLOGY (22) was the journal with the largest number of published publications (75), followed by FRONTIERS IN ONCOLOGY (15) and CANCERS (13). …”
Get full text
Article -
1064
ZEB1 shapes AML immunological niches, suppressing CD8 T cell activity while fostering Th17 cell expansion
Published 2024-02-01Get full text
Article -
1065
-
1066
Radiosurgery and Stereotactic Brain Radiotherapy with Systemic Therapy in Recurrent High-Grade Gliomas: Is It Feasible? Therapeutic Strategies in Recurrent High-Grade Gliomas
Published 2022-08-01“…Material/Methods: All patients with histological diagnosis of HGG that suffered by recurrent disease diagnosed by magnetic resonance imaging (MRI), according to Response Assessment in Neuro-Oncology (RANO) criteria, after primary/adjuvant chemo-radiotherapy treatment and underwent to re-RT by SRS/FSRT were included in the analysis. …”
Get full text
Article -
1067
-
1068
Insights into Healthcare Professionals’ Perceptions and Attitudes toward Nanotechnological Device Application: What Is the Current Situation in Glioblastoma Research?
Published 2023-06-01“…To date, most scientific studies on nanomaterial development have focused on deepening the attitudes of end users and experts, leaving clinical practice implications unexplored. Neuro-oncology might be a promising field for the application of nanotechnologies, especially for malignant brain tumors with a low-survival rate such as glioblastoma (GBM). …”
Get full text
Article -
1069
-
1070
Robotic stereotactic radiosurgery for intracranial meningiomas in elderly patients: assessment of treatment efficacy and safety
Published 2024-01-01“…Tumor response was evaluated using the Response Assessment in Neuro-Oncology (RANO) criteria for meningiomas. Adverse effects were graded using the Common Terminology Criteria for Adverse Events (CTCAE) version 5.0 and a cox regression was performed to investigate possible predictors.ResultsWe identified 82 patients with 102 CK-treated lesions that matched the criteria for the first SRS. …”
Get full text
Article -
1071
Anlotinib as Monotherapy or Combination Therapy for Recurrent High-Grade Glioma: A Retrospective Study
Published 2023-07-01“…Evaluation of treatment response was performed according to RANO (response assessment in neuro-oncology, RANO) criteria, including 21 partial response, 6 stable disease, and 2 PFS events. …”
Get full text
Article -
1072
-
1073
-
1074
Evaluation of Baculoviruses as Gene Therapy Vectors for Brain Cancer
Published 2023-02-01“…We compared them with adenoviral vectors (AdV), which are used in neuro-oncology, but for which there is pre-existing immunity. …”
Get full text
Article -
1075
361 WDR5 represents a therapeutically exploitable target for cancer stem cells in glioblastoma
Published 2023-04-01Get full text
Article -
1076
-
1077
Clinical practice guidelines for the diagnosis and treatment of adult diffuse glioma‐related epilepsy
Published 2019-08-01“…Methods In March 2017, the Joint Task Force for GRE of China Association Against Epilepsy and Society for Neuro‐Oncology of China launched the guideline committee for the diagnosis and treatment of GRE. …”
Get full text
Article -
1078
-
1079
-
1080
Phenotypic Plasticity of Invasive Edge Glioma Stem-like Cells in Response to Ionizing Radiation
Published 2019-02-01Get full text
Article